CRD REDCap • Inmunomodulación parasitaria • Nuevas terapias
Establecimiento de nuevas colaboraciones público/privadas para llevar a cabo proyectos innovadores en salud humana.
Búsqueda de estudiantes de doctorado con rendimiento académico excelente.
Creación y diseño de CRD (cuadernos de recogida de datos) para registros de pacientes / estudios clínicos mediante REDCap.
Búsqueda de nuevas terapias para enfermedades humanas basadas en moléculas inmunomoduladoras de parásitos.
Búsqueda de nuevas herramientas de diagnóstico inmunológico y parasitológico.
19 de enero de 2026
Vicente Emilio Larraga Rodríguez de Vera
Vicente Emilio Larraga Rodríguez de Vera earned degrees in Medicine and Surgery as well as in Biological Sciences from the Complutense University of Madrid. He completed postdoctoral studies at the Hebrew University and the Weizmann Institute of Science in Israel, as well as at Johns Hopkins University in the United States. He has also served as a visiting scientist at the School of Medicine of New York University.
His scientific career has focused on the structure of biological membranes and the mechanisms of cellular activation in both bacteria and eukaryotic cells at the Spanish National Research Council (CSIC). He founded the Molecular Parasitology Laboratory at the CSIC’s Center for Biological Research (Centro de Investigaciones Biológicas, CIB). His research has also addressed the development of recombinant vaccines against Leishmania infantum and the elucidation of infection mechanisms.
Currently, his work concentrates on gene activation in cells responsible for inducing protective immune responses against the parasite in the primary host of leishmaniosis, the dog. He has served as Vice-President of the CSIC and was Director of the Center for Biological Research in Madrid.
Dr. Larraga has authored over one hundred scientific publications in international journals and books. He is a member of several scientific societies, including the New York Academy of Sciences, the Spanish Society for Biochemistry and Molecular Biology, and the Spanish Society for Tropical Medicine and International Health. He is also a member of the Royal National Academy of Pharmacy.
Masterclass title: “Vacunas de ADN. Nuevas vacunas para enfermedades de siempre”.
Lunes 19 de enero de 2024 - 11:30 (UTC+1) - Aula B - Facultad de Farmacia
Universidad Complutense de Madrid
11 de diciembre de 2025
María Miró Navarro BSc, MSc, is a PhD student at the University of Bern. She was working as Research Assistant in Dr. Salman’s Lab at the Jenner Institute, University of Oxford. Her work contributed to the advancement of innovative vaccines that target infectious diseases caused by both human and veterinary pathogens, leading to improved strategies in global health.
Masterclass title: “Del ciclo del parásito al ensayo clínico: innovación y optimización en la vacuna contra la malaria R21/Matrix-M”
Jueves 11 de diciembre de 2024 - 11:30 (UTC+1) - Aula B - Facultad de Farmacia
Universidad Complutense de Madrid
6 de mayo de 2025
María Piedad de la Hoz Martín, Graduada en Farmacia y alumna del programa de Doctorado en Microbiología y Parasitología de la Universidad Complutense de Madrid
Título del seminario: “¿Cómo ha evolucionado la parasitología?”
Miércoles 7 de mayo de 2025 - 13:30 (UTC+1) - Aula B - Facultad de Farmacia
Universidad Complutense de Madrid
27 de Febrero de 2025
Seminario de investigación
jueves 27 de Febrero a las 16:00
Sala del Colegio Oficial de Farmacéuticos (Facultad de Farmacia)
Profesor Víctor Jiménez Cid, Departamento de Microbiología y Parasitología (UCM)
A los estudiantes de doctorado que asistan a dicho seminario se les otorgará un certificado de participación. Para ello deberán rellenar la siguiente encuesta de Google: